PELA-1267

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePELA-1267
Drug Alias NamePELA-1267
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsInflammationCoronary Artery DiseaseAlzheimer Disease +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPelagos Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPelagos Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsInflammationCoronary Artery DiseaseAlzheimer Disease +[7] 

Other Information

ATC CodeN/A
Related LinksN/A